Yale Cancer Center

Disparities in Breast Cancer–related Lymphedema: A Systematic Review of Inequities and Barriers in Care Breast cancer–related lymphedema (BCRL) is a chronic condition secondary to multimodal cancer treatment. This systematic review summarized the evidence for disparities and barriers surrounding BCRL ca...

Improving QOL for pts with #breastcancer related #lymphedema requires timely diagnosis, education, + access to care. Vulnerable populations face the greatest barriers highlighting the need for surveillance + support.
pmc.ncbi.nlm.nih.gov/articles/PMC...
#BCRL @yaleschoolofmed.bsky.social

James Elia has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from the #NIH for his project “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.”
yalecancercenter.org/news-article...

The Ninth Edition TNM Stage Classification of Lung Cancer: What’s New? A universal nomenclature to describe the anatomic extent of lung cancer has been critical for individual patient care and for advances in research. As progress continues, new details emerge that need ...

Drs. Frank Detterbeck and James Huang have led the update of the 9th edition #TNM classification for #LungCancer, refining N2/M1c categories and reorganizing stage groups.
semthorcardiovascsurg.com/article/S104...

Dr. Kiran Turaga joins Dr. Eric Winer tonight at 7:30pm for #appendixcancerawarenessmonth. Dr. Turaga explains how surgeons identify and treat #appendixcancer, and discusses research that shows an ⬆️ in young adult cases.
🔸 Listen live on #WNPR
🔸 Download #ApplePodcasts
🔸 Watch on #YouTube

Drug-induced #pneumonitis is a serious complication in #LungCancer therapy. In a #Thieme review, Drs. Kathleen McAvoy + Jennifer Possick @yalepccsm.bsky.social outline how early recognition, tailored monitoring + multidisciplinary care can ⬇️ morbidity + mortality. thieme-connect.com/products/ejo...

Factors Associated With Timely Receipt of Colposcopy After... : Journal of Lower Genital Tract Disease e of index abnormal cervical cancer screening requiring colposcopy follow-up from 3 separate years: 2016, 2018, and 2021. Primary outcomes included colposcopy attendance and timely colposcopy evaluati...

Dr. Sangini Sheth, et al. found that despite gains in guideline-concordant #colposcopy attendance, gaps in timely follow-up persist. Younger patients, smokers are less likely to receive timely care highlighting the need for targeted interventions.
journals.lww.com/jlgtd/abstra...
#JLGTD

Drs. Frank Detterbeck + Lynn Tanoue et al. led a new study showing early evidence linking irregular air-filled cysts with early-stage #lungcancers.
thieme-connect.com/products/ejo...
#Thieme

Yale Urology researchers developed an #EPIC EHR-integrated Care Pathway for #AUA guidelines for non-muscle invasive #bladdercancer + early results show promise for improving guideline-based, standardized care.
auajournals.org/doi/10.1097/...
#NMIBC

Yale New Haven Hospital is the Number One Hospital in Connecticut and the only hospital in the state to be nationally ranked by U.S. News & World Report NEW HAVEN, CT (July 29, 2025) – Yale New Haven Hospital ranks nationally in 11 specialties

We are honored to announce that Smilow Cancer Hospital is ranked one of the highest for #cancer care in the country by
@usnews.com + the top choice for #cancercare in #Connecticut!
➡️http://ynh.care/Oi

Opinion | The surprisingly simple treatment that could transform cancer care This low-tech intervention could fundamentally shift how we treat cancer patients.

Exercise is a proven, life-extending intervention for #cancer survivors, according to a landmark @nejm.org study and editorial by Dr. Melinda Irwin. As this @washingtonpost.com op-ed argues, cutting research funding now would be a devastating setback.
washingtonpost.com/opinions/202...

Dr. Alisa Rybkin et al. explain how distant relapse has become the key challenge as #radiotherapy improves locoregional control in locally advanced nasopharyngeal carcinoma #LANPC. Optimizing systemic therapy + ⬇️ toxicity is critical to improve outcomes.
jamanetwork.com/journals/jamao…

Oncology nutrition specialists Maura Harrigan @yalesph.bsky.social and Dr. Leah Ferrucci join Dr. Eric Winer tonight to discuss #nutrition for #cancer recovery + #survivorship.
▪️ Listen live on WNPR
▪️Download Apple Podcasts
▪️Watch on YouTube
@yaleschoolofmed.bsky.social

Congratulations to Dr. David Carlson, elected Science Council Vice Chair for @astro-org.bsky.social! Dr. Carlson will help guide ASTRO’s scientific initiatives including industry collaborations + funding opportunities.
astro.org/news-and-pub...
@yaleschoolofmed.bsky.social

Congratulations to Dr. Etienne Leveille, recipient of a postdoctoral fellowship grant from the Lymphoma Research Foundation!
➡️ medicine.yale.edu/news-article...
@yaleschoolofmed.bsky.social

Congratulations to the 7 members of @yalecancer.bsky.social to receive funding as Colton Center for Autoimmunity awardees!
ventures.yale.edu/news/yales-c...
@yaleventures.bsky.social

New Insights into Why Immunotherapy Works for Some Patients with Cancer, Not Others A groundbreaking study reveals that naturally occurring autoantibodies can boost or hinder cancer immunotherapy effectiveness by up to 10-fold, offering new

A new @nature.com study led by Drs. Harriet Kluger + @aaronmring.bsky.social reveals naturally-occurring autoantibodies can boost or block #immunotherapy effectiveness by up to 10x. This breakthrough may explain why treatments only work for some patients.
bit.ly/4kWIb1n
@fredhutch.bsky.social

RSVP: Community Level #LiverDisease Prevention
Participate in a dialogue on community-level prevention of chronic liver disease between #YaleLiverCenter and the #Connecticut Department of #PublicHealth.
🗓️August 28, 2025
⌚️11:30am-5:30pm
📍The Anylan Center, New Haven
➡️http://bit.ly/44OSkHm

Dr. Sylvia Kurz joins Dr. Eric Winer tonight at 7:30pm for a discussion on the evolving field of neuro-oncology, as well as breakthroughs and patient treatment strategies.
🔹Listen live on WNPR
🔹Download Apple Podcasts
🔹Watch on YouTube
@yaleschoolofmed.bsky.social

🚨Registration is open🚨
Yale Advancements in Oncology: Implementing the Best Science from ASCO® 2025 and Beyond
🗓️Friday, Sept. 26
🕖7:15am-3:30pm
📍New Haven Lawn Club
RSVP: bit.ly/40fPHgq

Drs. David Braun and Sidi Chen Receive CRI CLIP and Technology Impact Awards David Braun, MD, PhD, assistant professor of medicine (medical oncology and hematology) and a Louis Goodman and Alfred Gilman Yale Scholar, and Sidi Chen, PhD,

Congratulations @braunmdphd.bsky.social + Dr. Sidi Chen, named Clinical Laboratory Integration Program (CLIP) awardees by @cancerresearchinst.bsky.social! CLIP supports early-phase studies that test the translational potential of new immunotherapy approaches.
medicine.yale.edu/news-article...

Opinion: Perioperative ICIs Represent New Standard for HNSCC Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

Perioperative ICIs represent a new standard of care in head and neck cancer: an opinion piece by Barbara Burtness, MD, of @yalecancer.bsky.social. shorturl.at/h5Xhs #hncsm

A study of #bloodglucose in women with #breastcancer found levels ⬇️ slightly during chemotherapy vs. baseline. Without proper management, these changes may ⬆️ the risk of morbidity + mortality.
clinical-breast-cancer.com/article/S152...
@maryamlustberg.bsky.social

Dr. David Rimm + @yalepathology.bsky.social colleagues have developed Troplex, a test that measures #HER2 & #TROP2 levels in #breastcancer tumors—helping oncologists choose the most effective antibody-drug conjugates. bit.ly/457oUp7
@ascocancer.bsky.social

Yale Researchers Develop Novel Antibody-RNA Therapy for Resistant Cancers A modified antibody-RNA therapy gets by the defenses of hard-to-reach and hard-to-treat cancers.

Yale researchers engineered an antibody, #TMAB3, to carry immune-activating RNA directly to hard-to-treat tumors-shrinking tumors, ⬆️ survival, + avoiding healthy tissue. “This lays the foundation for personalized, tumor-targeted RNA therapies,” says Dr. Luisa Escobar-Hoyos.
bit.ly/3IyDIEq

Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

A new study with Drs. Jan Bewersdorf and Amer Zeidan
shows adding durvalumab to azacitidine did not improve response or survival in older pts with #AML or HR #MDS, even in those with RNA splicing factor mutations.
journals.sagepub.com/doi/10.1177/...
@yale-hematology.bsky.social

Effects of oral nicotine pouches on cigarette smoking behaviour and tobacco harm exposure: a randomised pilot trial in adults Oral nicotine pouches may have potential for smoking cessation, but scientific evidence on the effects of pouches and their constituents on smoking behaviour is limited. Design This study was a 4-wee...

A new study led by @lisafucito.bsky.social explored oral #nicotine pouches for #smokingcessation + found prelim support for their use as a cigarette substitute. Higher-nicotine pouches may have a stronger impact on smoking behavior.
tobaccocontrol.bmj.com/content/earl...
@bmj.com #tobacco

The Impact and Safety of GLP‐1 Agents and Breast Cancer Weight gain is a common side effect of breast cancer treatment and is associated with increased cancer progression and mortality. GLP-1 receptor agonists are emerging as potential weight loss therapi....

Addressing obesity can help improve outcomes in #breastcancer. A new study from @maryamlustberg.bsky.social + colleagues finds no major safety concerns with #GLP1 meds so far, but more research is needed on safe, effective, long-term weight loss options. onlinelibrary.wiley.com/doi/10.1002/...

Results from the AMBER part 2B trial reveal cobolimab + dostarlimab as safe with promising efficacy in advanced/metastatic #NSCLC. Findings support continued investigation in this population.
aacrjournals.org/clincancerre...
@theaacr.bsky.social

Congratulations to Dr. Zhe (Jay) Chen, selected by
@astro-org.bsky.social to receive the ASTRO Fellow #FASTRO designation recognizing significant contributions to #radiationoncology through research, education, patient care and service.
yalecancercenter.org/news-article...

Dr. Pamela Kunz joins Dr. Eric Winer tonight at 7:30pm for a discussion on decoding common #cancermyths and what patients should know about navigating misinformation online.
🔹Listen live on WNPR
🔹Download Apple Podcasts
🔹Watch on YouTube
@yaleschoolofmed.bsky.social